Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis. [PDF]
J Manag Care Spec PharmDerSarkissian M +7 more
europepmc +1 more source
A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023. [PDF]
CureusMaverakis Ramirez N, Jaeger ZJ, Lee DJ.
europepmc +1 more source
Rationale of renewed efforts in developing MC4R modulators to treat metabolic disorders. [PDF]
Acta Pharm Sin BFeng W, Zhou Q, Wang MW.
europepmc +1 more source
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias. [PDF]
Am J Clin DermatolVu TN +8 more
europepmc +1 more source
Acute on chronic liver failure in erythropoietic protoporphyria: A case report and review of the literature. [PDF]
Hepatol ForumViswanath A +6 more
europepmc +1 more source
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. [PDF]
Int J Mol SciRenke G, Chinellato L.
europepmc +1 more source
Vitiligo-Current Treatment Options and Future Perspectives. [PDF]
Int J Mol SciWojno A +5 more
europepmc +1 more source
Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes. [PDF]
J Pers MedBaffa ME +8 more
europepmc +1 more source
Recent Advances in Management of Vitiligo. [PDF]
Indian J DermatolDas K, Sarkar R, Sinha S.
europepmc +1 more source
Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. [PDF]
Life (Basel)Bonchev A.
europepmc +1 more source